Discovery of JW0061, a Novel GFRA1 Agonist, as a Hair Regeneration Stimulant via WNT Signaling Activation in Dermal Papilla Cells

July 2024 in “ Journal of Investigative Dermatology ”

Ahyoung Yoo, Junho Park, Grace Kim, Sujin Kim, Soo Young Choi, Nahyun Kim, Junho Park, Daijin Ko, Jeong Hun Jang, I. Im, Chang Hwa Jung, Mi‐Ae Park, Dean A. Lee, Ahreum Baek, B J Byun, Tae‐Cheon Kang, Wei Hong, Jinhe Kang, Chung‐Gyu Park

JW0061 GFRA1 agonist WNT signaling dermal papilla cells GFRA1-RET signaling β-catenin hair follicle growth anagen induction androgenetic alopecia hair regeneration WNT activator hair growth stimulant hair follicle activation

TLDR JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

JW0061 is a novel small molecule identified as a WNT activator that stimulates hair regeneration by activating WNT signaling in dermal papilla cells. It binds directly to GFRA1, triggering the GFRA1-RET signaling cascade and stabilizing β-catenin, which enhances hair follicle growth and differentiation. The compound has shown efficacy in promoting faster hair follicle anagen induction and hair shaft growth in various models, including human skin organoids. With promising safety data from GLP toxicology studies and an IND submission in progress, JW0061 presents a potential new treatment for androgenetic alopecia, addressing the limited options currently available.

View this study on jidonline.org →

Discuss this study in the Community →

Related Community Posts Join

6 / 8 results

community Why is nobody studying the difference between donor and balding hair?

in Chat 89 upvotes 1 year ago

The conversation discusses why the difference between donor and balding hair isn't studied more to find a cure for hair loss. Treatments mentioned include Minoxidil, finasteride, and RU58841.

community JW Pharmaceutical shows superiority of 'JW0061' in hair growth over existing treatments in US

in Research/Science 99 upvotes 1 year ago

JW0061 shows superior hair growth results compared to existing treatments, with significant increases in hair follicles. The Wnt/β-catenin pathway is crucial for hair growth, and JW0061 activates this pathway effectively.

community Cure/better treatment options in the future

in Chat 11 upvotes 1 year ago

The conversation is about future hair loss treatments. Current treatments mentioned include finasteride, minoxidil, and RU58841, with potential future treatments like GT20029, TDM-105795, JW0061, and follicle cloning.

community (Serious) Updates and discussion, new treatments in development

in Treatment 7 upvotes 1 year ago

Finasteride, minoxidil, and derma rolling are currently the best treatments for hair loss. New treatments like TDM-105795, GT20029, PP405, HMI 115, Tsuji, Scube 3, RU, JW0061, Topilutamide, and verteporfin show promise but have uncertain timelines.

community Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases

in Research/Science 35 upvotes 1 year ago

Finasteride, Minoxidil, Bioneer CosmeRNA, Technoderma, Kintor, Hope, Breezula, and Follicum treatments showed increases in hair count, with Technoderma showing the highest increase at 24.3 hairs/cm². Amplifica has not yet published results.

community Status update on upcoming treatments

in Technology 44 upvotes 3 months ago

Current treatments for hair loss include finasteride, minoxidil, and derma rolling. New treatments like Breezula, PP405, and others are not expected until at least 2027 or later.

Related Research

1 / 1 results

research Temporal-Spatial Activation of Wnt-Signaling Within Type 1 and Type 2 Immunity During Wound Healing

April 2019 in “Journal of Investigative Dermatology”

Wnt-signaling is regulated differently in skin cells and immune responses during wound healing.